Results 51 to 60 of 275 matches
Category 3 - THERAPEUTIC PROCEDURES
14115 - Additional Information
Laser photocoagulation using laser radiation in the treatment of vascular malformations, infantile haemangiomas, café au lait macules and naevi of Ota, other than melanocytic naevi (common moles), including any associated consultation, up to a maximum of 6 sessions (including any sessions to which this item or any of items 14100 to 14118 apply) in any 12 month period—area of treatment 150 cm2 to 300 cm2
(Anaes.)
Fee: $282.30 Benefit: 75% = $211.75 85% = $240.00
(See para TN.1.15 of explanatory notes to this Category)
Category 3 - THERAPEUTIC PROCEDURES
14118 - Additional Information
Laser photocoagulation using laser radiation in the treatment of vascular malformations, infantile haemangiomas, café au lait macules and naevi of Ota, other than melanocytic naevi (common moles), including any associated consultation, up to a maximum of 6 sessions (including any sessions to which this item or any of items 14100 to 14115 apply) in any 12 month period—area of treatment more than 300 cm2
(Anaes.)
Fee: $358.50 Benefit: 75% = $268.90 85% = $304.75
(See para TN.1.15 of explanatory notes to this Category)
Category 3 - THERAPEUTIC PROCEDURES
14124 - Additional Information
Laser photocoagulation using laser radiation in the treatment of vascular malformations, infantile haemangiomas, café‑au‑lait macules and naevi of Ota, other than melanocytic naevi (common moles), including any associated consultation, if:
(a) a seventh or subsequent session (including any sessions to which this item or any of items 14100 to 14118 apply) is indicated in a 12 month period commencing on the day of the first session; and
(b) photographic evidence demonstrating the need for this service is documented in the patient notes
(Anaes.)
Fee: $167.85 Benefit: 75% = $125.90 85% = $142.70
(See para TN.1.15 of explanatory notes to this Category)
Category 3 - THERAPEUTIC PROCEDURES
15338 - Additional Information
Prostate, radioactive seed implantation of, radiation oncology component, using transrectal ultrasound guidance:
(a) for a patient with:
(i) localised prostatic malignancy at clinical stages T1 (clinically inapparent tumour not palpable or visible by imaging) or T2 (tumour confined within prostate); and
(ii) a Gleason score of less than or equal to 7 (Grade Group 1 to Grade Group 3); and
(iii) a prostate specific antigen (PSA) of not more than 10ng/ml at the time of diagnosis; and
(b) performed by an oncologist at an approved site in association with a urologist; and
(c) being a service associated with:
(i) services to which items 37220 and 55603 apply; and
(ii) a service to which item 60506 or 60509 applies
Fee: $1,029.80 Benefit: 75% = $772.35 85% = $931.10
(See para TN.2.2 of explanatory notes to this Category)
Category 3 - THERAPEUTIC PROCEDURES
15850 - Additional Information
RADIATION SOURCE LOCALISATION using a simulator, x-ray machine, CT or ultrasound of a single area, where views in more than one plane are required, for brachytherapy treatment planning, not being a service to which Item 15513 applies.
Fee: $219.60 Benefit: 75% = $164.70 85% = $186.70
Category 3 - THERAPEUTIC PROCEDURES
16522 - Additional Information
Management of labour and birth, or birth alone, (including caesarean section), on or after 23 weeks gestation, if in the course of antenatal supervision or intrapartum management one or more of the following conditions is present, including postnatal care for 7 days:
(a) fetal loss;
(b) multiple pregnancy;
(c) antepartum haemorrhage that is:
(i) of greater than 200 ml; or
(ii) associated with disseminated intravascular coagulation;
(d) placenta praevia on ultrasound in the third trimester with the placenta within 2 cm of the internal cervical os;
(e) baby with a birth weight less than or equal to 2,500 g;
(f) trial of vaginal birth in a patient with uterine scar where there has been a planned vaginal birth after caesarean section;
(g) trial of vaginal breech birth where there has been a planned vaginal breech birth;
(h) prolonged labour greater than 12 hours with partogram evidence of abnormal cervimetric progress as evidenced by cervical dilatation at less than 1 cm/hr in the active phase of labour (after 3 cm cervical dilatation and effacement until full dilatation of the cervix);
(i) acute fetal compromise evidenced by:
(i) scalp pH less than 7.15; or
(ii) scalp lactate greater than 4.0;
(j) acute fetal compromise evidenced by at least one of the following significant cardiotocograph abnormalities:
(i) prolonged bradycardia (less than 100 bpm for more than 2 minutes);
(ii) absent baseline variability (less than 3 bpm);
(iii) sinusoidal pattern;
(iv) complicated variable decelerations with reduced (3 to 5 bpm) or absent baseline variability;
(v) late decelerations;
(k) pregnancy induced hypertension of at least 140/90 mm Hg associated with:
(i) at least 2+ proteinuria on urinalysis; or
(ii) protein-creatinine ratio greater than 30 mg/mmol; or
(iii) platelet count less than 150 x 109/L; or
(iv) uric acid greater than 0.36 mmol/L;
(l) gestational diabetes mellitus requiring at least daily blood glucose monitoring;
(m) mental health disorder (whether arising prior to pregnancy, during pregnancy or postpartum) that is demonstrated by:
(i) the patient requiring hospitalisation; or
(ii) the patient receiving ongoing care by a psychologist or psychiatrist to treat the symptoms of a mental health disorder; or
(iii) the patient having a GP mental health treatment plan; or
(iv) the patient having a management plan prepared in accordance with item 291;
(n) disclosure or evidence of domestic violence;
(o) any of the following conditions either diagnosed pre-pregnancy or evident at the first antenatal visit before 20 weeks gestation:
(i) pre-existing hypertension requiring antihypertensive medication prior to pregnancy;
(ii) cardiac disease (co-managed with a specialist physician and with echocardiographic evidence of myocardial dysfunction);
(iii) previous renal or liver transplant;
(iv) renal dialysis;
(v) chronic liver disease with documented oesophageal varices;
(vi) renal insufficiency in early pregnancy (serum creatinine greater than 110 mmol/L);
(vii) neurological disorder that confines the patient to a wheelchair throughout pregnancy;
(viii) maternal height of less than 148 cm;
(ix) a body mass index greater than or equal to 40;
(x) pre-existing diabetes mellitus on medication prior to pregnancy;
(xi) thyrotoxicosis requiring medication;
(xii) previous thrombosis or thromboembolism requiring anticoagulant therapy through pregnancy and the early puerperium;
(xiii) thrombocytopenia with platelet count of less than 100,000 prior to 20 weeks gestation;
(xiv) HIV, hepatitis B or hepatitis C carrier status positive;
(xv) red cell or platelet iso-immunisation;
(xvi) cancer with metastatic disease;
(xvii) illicit drug misuse during pregnancy
(Anaes.)
Fee: $1,793.40 Benefit: 75% = $1,345.05
(See para TN.4.7 of explanatory notes to this Category)
Category 3 - THERAPEUTIC PROCEDURES
20216 - Additional Information
INITIATION OF MANAGEMENT OF ANAESTHESIA for intracranial vascular procedures including those for aneurysms or arterio-venous abnormalities
(20 basic units)
Fee: $436.00 Benefit: 75% = $327.00 85% = $370.60
Category 3 - THERAPEUTIC PROCEDURES
20745 - Additional Information
Initiation of the management of anaesthesia for any of the following:
(a) upper gastrointestinal endoscopic procedures in association with acute gastrointestinal haemorrhage;
(b) endoscopic retrograde cholangiopancreatography;
(c) upper gastrointestinal endoscopic ultrasound;
(d) percutaneous endoscopic gastrostomy;
(e) upper gastrointestinal endoscopic mucosal resection of tumour.
(7 basic units)
Fee: $152.60 Benefit: 75% = $114.45 85% = $129.75
Category 3 - THERAPEUTIC PROCEDURES
30439 - Additional Information
Intraoperative ultrasound of biliary tract, or operative cholangiography, if the service:
(a) is performed in association with an intra-abdominal procedure; and
(b) is not associated with a service to which item 30442 or 30445 applies
(Anaes.) (Assist.)
Fee: $204.25 Benefit: 75% = $153.20
(See para TN.8.208 of explanatory notes to this Category)
Category 3 - THERAPEUTIC PROCEDURES
30441 - Additional Information
Intraoperative ultrasound for staging of intra-abdominal tumours
(Anaes.)
Fee: $150.00 Benefit: 75% = $112.50
Results 51 to 60 of 275 matches
Legend
- Assist - Addition/Deletion of (Assist.)
- Amend - Amended Description
- Anaes - Anaesthetic Values Amended
- Emsn - EMSN Change
- Fee - Fee Amended
- Renum - Item Number Change (renumbered)
- New - New Item
- NewMin - New Item (previous Ministerial Determination)
- Qfe - QFE Change